about
Measles in the United Kingdom: can we eradicate it by 2010?Following in the footsteps of smallpox: can we achieve the global eradication of measles?Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan.The role of research in viral disease eradication and elimination programs: lessons for malaria eradicationThe Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract InfectionsPneumonia in South-East Asia Region: public health perspectivePredominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaquesFunctional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.Measles still has a devastating impact in unvaccinated populations.Measles mimicking HIV seroconversion syndrome: a case reportSubacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralizationOncolytic viruses: From bench to bedside with a focus on safety.Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy.Measles in a tertiary institution in bida, niger state, Nigeria: prevalence, immunization status and mortality pattern.8 management of allergy, rashes, and itchingMatrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization.Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi.Severe Measles Infection: The Spectrum of Disease in 36 Critically Ill Adult PatientsThe receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitopeMeasles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern ChinaMeasles Outbreak among Previously Immunized Adult Healthcare Workers, China, 2015Vaccines to prevent pneumonia and improve child survival.Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccineRoutine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.Management of community-acquired pneumonia in HIV-infected children.Spotlight on measles in Italy: why outbreaks of a vaccine-preventable infection continue in the 21st century.Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.Measles virus neurovirulence and host immunity.Case-fatality rate during a measles outbreak in eastern Niger in 2003.Measles in a previously vaccinated human immunodeficiency virus-positive adult.Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak.
P2860
Q24678331-1E171357-C3DE-43DA-9A9F-C5671715FF37Q24805231-33271226-647D-4FCF-8FBA-911A7F4BBE61Q24813444-D31953AD-6B7A-4FDB-BC8F-6B7F2FD5E631Q26700366-07A85363-C931-4DFF-973E-38DD1A03854EQ26752322-94E39BC0-64B2-4BE6-A245-21D71EE3BEB0Q27027095-D36D9D8A-FC9D-490D-B167-AEBB219B653FQ27319538-196A9CF4-FEF2-45F2-A7C1-CB9EC367677EQ30423044-2D44E251-DED7-41B6-886B-6A1C0197E053Q30828665-F18414AC-873A-4BD6-B22E-62F2882AA799Q33692443-DF0B1493-48F0-4D31-9824-A68ECED9E1AEQ33796521-6F6E46F3-A9D6-462E-BFE2-790D5ECE6895Q33875725-308E45DF-9D9D-4861-8855-099300EFD72FQ33930445-03B8CA35-FFC4-4B37-AD1F-4B18FC566671Q34044071-A29D5766-F3D8-454D-AA86-3C9A8B432825Q34554618-EE02B414-2DDC-43F3-9276-486A9AEB4D87Q35183718-93AEC9E6-73A0-47CC-B042-849294C43E7FQ35323973-90B1ECBA-F50F-4E0D-A38B-D761C9140E9FQ35343971-3A857CC4-AF4C-40ED-8C6C-72E60FE4C21AQ35363225-63A1EAA0-D06B-47B4-B65F-7A049CBA3987Q35734934-C7784C9A-C89F-4B94-91D0-9DE9192D33BAQ36008978-FA34CC46-0AD5-4D1B-A34F-5F2AD3F16515Q36667843-AD18A780-2B7E-4B9B-A738-8AB4F3875ED6Q36977610-78250817-1480-4C13-A9C8-0ACD26604381Q36996849-D8662159-4E5C-4D37-B028-4CCFAC6753D3Q37108802-E8C8141A-D704-4289-A480-D2A001E5FA02Q37138504-C0C6E521-FB38-4122-B009-DA91F4A4E0BCQ37405340-E7EB817A-B9AE-4EA1-BD07-53412FB52B49Q37463218-0BB2EDD7-A89C-49FC-809B-CA20E87CF53CQ38328812-BBA421E2-D607-4F95-866E-1A033B0151E6Q38860948-7E552807-A331-46AB-B3AA-B2E46E21A0B5Q39764446-6DA24DF1-38EC-49F3-B813-AFFDDCD43FF2Q40489525-2FDD8657-8293-4711-A0FA-D238A7A448C9Q42248916-782C63D0-2893-48AC-A982-4000F987F588Q42264822-69BE8098-48EA-4A48-8D64-E9B95912B9F1
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Measles: not just another viral exanthem.
@ast
Measles: not just another viral exanthem.
@en
type
label
Measles: not just another viral exanthem.
@ast
Measles: not just another viral exanthem.
@en
prefLabel
Measles: not just another viral exanthem.
@ast
Measles: not just another viral exanthem.
@en
P1433
P1476
Measles: not just another viral exanthem.
@en
P2093
Charles S Mgone
Trevor Duke
P304
P356
10.1016/S0140-6736(03)12661-X
P407
P577
2003-03-01T00:00:00Z